Vox Markets Logo

JPMorgan 'repositioning for a recovery' as it upgrades host of housebuilders

12:24, 12th April 2024

JPMorgan Cazenove upgraded a host of names in the housebuilding sector on Friday as it said it was "repositioning for a recovery".
JPM said: "Overall, despite the backdrop of a likely subdued 2024E from an operational perspective, we take a more positive stance on the sector this year, as we see scope for likely positive sentiment/newsflow from the upcoming UK election (with housing expected to be a key focus) before positioning for a recovery in 2025E, likely aided by rate cuts.

"Furthermore, irrespective of which political party wins the upcoming election, we expect the Government to increasingly focus on boosting affordable housing and reforming the planning system in coming years."

The bank lifted its stance on Barratt Developments (BDEV) Follow | BDEV,  Persimmon (PSN) Follow | PSN and Taylor Wimpey (TW.) Follow | TW. to 'overweight' from 'neutral'. The price targets were upped to 560p from 370p, to 1,510p from 1,190p and to 150p from 101p, respectively.

JPM upgraded Redrow to 'neutral' from 'underweight', bumping up the price target to 760p from 410p.

Vistry was upgraded to 'overweight' from 'underweight' and the price target hiked to 1,380p from 580p.

The bank said it sees Persimmon, Taylor Wimpey and Vistry as key beneficiaries of boosting affordable homes/reforming planning.

As far as Barratt is concerned, JPM said it sees an attractive entry-point given the year-to-date move (-19%) and compelling investment case with the proposed acquisition of Redrow (subject to closing).

JPMorgan downgraded Bellway and Berkeley to 'neutral' from 'overweight' and lifted the price target on Bellway to 2,780p from 2,170p.

Stock Chart | BDEV


Stock Chart | PSN


Stock Chart | TW.

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Recent Articles